Advancing Biomarker Validation for Drug Hypersensitivity
Physician's Weekly
JUNE 16, 2025
But the varied mechanisms and clinical presentations of drug hypersensitivity reactions (DHRs) can make diagnosis and treatment challenging, and most biomarkers still require validation. The mechanisms underlying DHRs are complex and diagnosis requires a detailed in vivo and in vitro assessment on an individual basis.
Let's personalize your content